Clinical Trial Update: Efficacy of Islet After Kidney Transplantation [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating islet transplantation after kidney transplantation for Type 1 Diabetes Mellitus has completed, with reported efficacy outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Type 1 Diabetes Mellitus | Phase 3 | Status: COMPLETED